IL313226A - Please treat diseases in a sex-specific manner - Google Patents

Please treat diseases in a sex-specific manner

Info

Publication number
IL313226A
IL313226A IL313226A IL31322624A IL313226A IL 313226 A IL313226 A IL 313226A IL 313226 A IL313226 A IL 313226A IL 31322624 A IL31322624 A IL 31322624A IL 313226 A IL313226 A IL 313226A
Authority
IL
Israel
Prior art keywords
nap
sex
diseases
specific treatment
treatment
Prior art date
Application number
IL313226A
Other languages
English (en)
Hebrew (he)
Inventor
Illana Gozes
Gidon Karmon
Alexandra Lobyntseva
Guy Shapira
Noam Shomron
Original Assignee
Univ Ramot
Illana Gozes
Gidon Karmon
Alexandra Lobyntseva
Guy Shapira
Noam Shomron
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Ramot, Illana Gozes, Gidon Karmon, Alexandra Lobyntseva, Guy Shapira, Noam Shomron filed Critical Univ Ramot
Publication of IL313226A publication Critical patent/IL313226A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Zoology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
IL313226A 2021-12-14 2022-12-13 Please treat diseases in a sex-specific manner IL313226A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163289174P 2021-12-14 2021-12-14
US202263306146P 2022-02-03 2022-02-03
PCT/IL2022/051314 WO2023112025A1 (en) 2021-12-14 2022-12-13 Nap for sex-specific treatment of diseases

Publications (1)

Publication Number Publication Date
IL313226A true IL313226A (en) 2024-07-01

Family

ID=86773996

Family Applications (1)

Application Number Title Priority Date Filing Date
IL313226A IL313226A (en) 2021-12-14 2022-12-13 Please treat diseases in a sex-specific manner

Country Status (9)

Country Link
US (1) US20250312408A1 (https=)
EP (1) EP4447994A4 (https=)
JP (1) JP2025501458A (https=)
KR (1) KR20240135692A (https=)
AU (1) AU2022410066A1 (https=)
CA (1) CA3240138A1 (https=)
IL (1) IL313226A (https=)
MX (1) MX2024006777A (https=)
WO (1) WO2023112025A1 (https=)

Also Published As

Publication number Publication date
EP4447994A1 (en) 2024-10-23
CA3240138A1 (en) 2023-06-22
WO2023112025A1 (en) 2023-06-22
AU2022410066A1 (en) 2024-07-25
MX2024006777A (es) 2024-08-06
KR20240135692A (ko) 2024-09-11
JP2025501458A (ja) 2025-01-22
US20250312408A1 (en) 2025-10-09
EP4447994A4 (en) 2026-01-07

Similar Documents

Publication Publication Date Title
IL276383A (en) Treatment of ophthalmological diseases
IL289405A (en) Personalized treatment of eye diseases
PL3959213T3 (pl) Pirymidynowe inhibitory JAK w leczeniu chorób skóry
SG11202007082PA (en) Composition used for therapeutic treatment of skin disease
IL287802A (en) Preparations and methods for the treatment of eye diseases
GB201805100D0 (en) Treatment of sarcopenic diseases
IL282360A (en) Treatment for neurological diseases
SG11202001595SA (en) Angio-3 for treatment of retinal angiogenic diseases
ZA202002075B (en) Compounds, compositions and methods for treatment of eye disorders and skin diseases
IL304628A (en) Treatment of skin disorders
GB2595513B (en) Treatment of infections
GB202015959D0 (en) Treatment of diseases involving NAD
IL313226A (en) Please treat diseases in a sex-specific manner
GB202001353D0 (en) Treatment of skin conditions
IL307205A (en) Perilesional treatment of skin conditions
GB202108485D0 (en) Treatment of inflammatory conditions or diseases
GB202002291D0 (en) Treatment of corneal vasularisation
GB201909438D0 (en) Treatment of diseases
GB202118007D0 (en) Methods of treatment
GB202118011D0 (en) Methods of treatment
GB202118006D0 (en) Methods of treatment
GB202103975D0 (en) Treatment of HS
GB202108245D0 (en) Methods of treatment
GB202108242D0 (en) Methods of treatment
GB202104753D0 (en) Treatment of ophthalmological conditions